CIK 0001109354
- Large accelerated filer
BRUKER CORP
Sign in to watch- Ticker
- BRKR
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043110160
- Phone
- +1 978-663-3660
- Business address
- 40 MANNING RD, BILLERICA, MA, 01821
- Former names
- BRUKER BIOSCIENCES CORP, BRUKER DALTONICS INC
Securities
- BRKR Common Stock Nasdaq
- BRKRP 6.375% Mandatory Convertible Preferred Stock, Series A Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $105,740
- in 1 filing
Net −$105,740. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-08-05 | Munch Mark EXEC VP&PRES BRUKER NANO INC. | Shares withheld for taxes | −986 | $63.54 | $63K | 99,725 |
| 2024-08-05 | LAUKIEN FRANK H PRESIDENT & CEO | Shares withheld for taxes | −3,582 | $63.54 | $228K | 38,322,925 |
| 2024-08-05 | Herman Gerald N EXECUTIVE VICE PRESIDENT, CFO | Shares withheld for taxes | −577 | $63.54 | $37K | 70,382 |
| 2024-03-04 | Requardt Hermann Fritz Director | Option exercise | +5,000 | $18.15 | $91K | 28,147 |
| 2024-03-04 | Requardt Hermann Fritz Director | Option exercise | +10,000 | $24.00 | $240K | 38,147 |
| 2024-03-04 | Requardt Hermann Fritz Director | Sale | −13,772 | $90.10 | $1.2M | 24,375 |
| 2024-03-04 | Requardt Hermann Fritz Director | Sale | −1,228 | $89.61 | $110K | 23,147 |
| 2024-03-04 | Requardt Hermann Fritz Director | Option exercise · Stock Option (Right to Purchase) | −5,000 | 0 | ||
| 2024-03-04 | Requardt Hermann Fritz Director | Option exercise · Stock Option (Right to Purchase) | −10,000 | 0 | ||
| 2024-02-28 | Busse Falko PRESIDENT, BIOSPIN GROUP | Option exercise | +12,000 | $19.82 | $238K | 44,859 |
| 2024-02-28 | Busse Falko PRESIDENT, BIOSPIN GROUP | Option exercise | +7,097 | $22.19 | $157K | 51,956 |
| 2024-02-28 | Busse Falko PRESIDENT, BIOSPIN GROUP | Option exercise | +4,384 | $34.02 | $149K | 56,340 |
| 2024-02-28 | Busse Falko PRESIDENT, BIOSPIN GROUP | Option exercise | +4,641 | $41.95 | $195K | 60,981 |
| 2024-02-28 | Busse Falko PRESIDENT, BIOSPIN GROUP | Sale | −13,852 | $86.06 | $1.2M | 47,129 |
| 2024-02-28 | Busse Falko PRESIDENT, BIOSPIN GROUP | Sale | −12,770 | $84.97 | $1.1M | 34,359 |
| 2024-02-28 | Busse Falko PRESIDENT, BIOSPIN GROUP | Sale | −1,500 | $84.48 | $127K | 32,859 |
| 2024-02-28 | Busse Falko PRESIDENT, BIOSPIN GROUP | Option exercise · Stock Option (Right to Purchase) | −12,000 | 0 | ||
| 2024-02-28 | Busse Falko PRESIDENT, BIOSPIN GROUP | Option exercise · Stock Option (Right to Purchase) | −7,097 | 0 | ||
| 2024-02-28 | Busse Falko PRESIDENT, BIOSPIN GROUP | Option exercise · Stock Option (Right to Purchase) | −4,384 | 0 | ||
| 2024-02-28 | Busse Falko PRESIDENT, BIOSPIN GROUP | Option exercise · Stock Option (Right to Purchase) | −4,641 | 0 |
Page 9 of 30 · 598 trades